Zedira
Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for R&D and diagnostics.
Press releases
Press
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharmato Develop First-in-Class Celiac Disease Therapy
Collaboration Provides Takeda an Exclusive License to Develop and Commercialize ZED1227/TAK-227 in the United States and Other Countries Outside of Europe, Canada, Australia and China
Agreement Adds Third Investigational Therapy to Takeda’s Pipeline for the Potential Treatment of Celiac Disease
Osaka, Japan, and Freiburg and Darmstadt, Germany, October 20, 2022 – Takeda, Zedira and Dr. Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/T
Info & Contact
Address
Roesslerstraße 83
64293 Darmstadt
64293 Darmstadt
In portfolio
03. Sep 2007